Scientific

MK5 Microarray Data


Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 183 to 232 of 3228 in total
Value Type: Measured
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1
\def\wcA{0.16666666666667\textwidth} \def\wcB{0.16666666666667\textwidth} \def\wcC{0.16666666666667\textwidth} \def\wcD{0.16666666666667\textwidth} \def\wcE{0.16666666666667\textwidth} \begin{longtable}{|c|c|c|c|c|} \hline \parbox{\wcA}{\vspace{3pt}\noindent Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent network\_comparison\vspace{3pt}}\\ \hline \hline \parbox{\wcA}{\vspace{3pt}\noindent 183\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent apobec-1 complementation factor isoform 1; apobec-1 stimulating protein; apo-b rna editing protein. [source:refseq;acc:nm\_014576]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 4069.83\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 5252.17\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.29051\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 184\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent ns1-associated protein 1. [source:refseq;acc:nm\_006372]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 185\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent heterogeneous nuclear ribonucleoprotein r (hnrnp r). [source:swissprot;acc:o43390]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 186\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent eukaryotic translation initiation factor 4 gamma (eif-4-gamma) (eif- 4g) (eif4g) (p220). [source:swissprot;acc:q04637]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 4071.1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5251.75\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.29001\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 187\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent small nuclear ribonucleoprotein sm d3 (snrnp core protein d3) (sm-d3). [source:swissprot;acc:p43331]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 4569.48\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5885.79\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.28807\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 188\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent source of immunodominant mhc-associated peptides; homolog of yeast stt3 gene. [source:refseq;acc:nm\_178862]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 4571.89\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 5864.86\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.28281\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 189\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent oligosaccharyl transferase stt3 subunit homolog (b5) (integral membrane protein 1) (tmc). [source:swissprot;acc:p46977]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 190\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kda subunit precursor (ec 2.4.1.119) (oligosaccharyl transferase 48 kda subunit) (ddost 48 kda subunit). [source:swissprot;acc:p39656]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 191\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent splicing factor 3b subunit 1 (spliceosome associated protein 155) (sap 155) (sf3b155) (pre-mrna splicing factor sf3b 155 kda subunit). [source:swissprot;acc:o75533]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 4638.1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5923.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.27712\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 192\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent a-raf proto-oncogene serine/threonine-protein kinase (ec 2.7.1.-) (a-raf-1) (proto-oncogene pks). [source:swissprot;acc:p10398]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 17757.5\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 14008\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.26767\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 193\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent raf proto-oncogene serine/threonine-protein kinase (ec 2.7.1.-) (raf-1) (c-raf). [source:swissprot;acc:p04049]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 17756.5\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 14007.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.26766\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 194\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent cyclin g2. [source:swissprot;acc:q16589]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 17738.6\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 13995.7\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.26743\vspace{3pt}}}\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 195\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent cyclin g1 (cyclin g). [source:swissprot;acc:p51959]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 17738.5\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 13995.6\vspace{3pt}}&\\\cline{1-2}\cline{4-5} \parbox{\wcA}{\vspace{3pt}\noindent 196\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent serine/threonine protein phosphatase 2a, 56 kda regulatory subunit, epsilon isoform (pp2a, b subunit, b' epsilon isoform) (pp2a, b subunit, b56 epsilon isoform) (pp2a, b subunit, pr61 epsilon isoform) (pp2a, b subunit, r5 epsilon isoform). [source:swissprot;acc:q16537]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 13995.7\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.26742\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 197\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent serine/threonine protein phosphatase 2a, 56 kda regulatory subunit, alpha isoform (pp2a, b subunit, b' alpha isoform) (pp2a, b subunit, b56 alpha isoform) (pp2a, b subunit, pr61 alpha isoform) (pp2a, b subunit, r5 alpha isoform). [source:swissprot;acc:q15172]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 198\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent b-raf proto-oncogene serine/threonine-protein kinase (ec 2.7.1.-) (p94) (v-raf murine sarcoma viral oncogene homolog b1). [source:swissprot;acc:p15056]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 17710.9\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 13977.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.26708\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 199\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent serine/threonine protein phosphatase 2a, catalytic subunit, alpha isoform (ec 3.1.3.16) (pp2a-alpha) (replication protein c) (rp-c). [source:swissprot;acc:p05323]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 4916.8\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 3888.18\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.26455\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 200\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent crk-associated substrate (p130cas) (breast cancer anti-estrogen resistance 1 protein). [source:swissprot;acc:p56945]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 4808.79\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6074.21\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.26315\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 201\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent t-complex protein 1, delta subunit (tcp-1-delta) (cct-delta) (stimulator of tar rna binding). [source:swissprot;acc:p50991]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 4810.22\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6075.04\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.26294\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 202\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent enhancer of filamentation 1 (hef1) (crk-associated substrate-related protein) (cas-l) (casl) (pp105) (neural precursor cell expressed developmentally down-regulated 9). [source:swissprot;acc:q14511]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 4812.01\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6076.09\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.26269\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 203\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent autophagy protein 12-like (apg12-like). [source:swissprot;acc:o94817]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 11757.8\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 9352.11\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.25723\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 204\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent small nuclear ribonucleoprotein e (snrnp-e) (sm protein e) (sm-e) (sme). [source:swissprot;acc:p08578]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 4512.19\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 5655.52\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.25339\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 205\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent small nuclear ribonucleoprotein f (snrnp-f) (sm protein f) (sm-f) (smf). [source:swissprot;acc:q15356]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 206\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent atlastin; guanylate-binding protein 3. [source:refseq;acc:nm\_015915]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5720.25\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 4577.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.24965\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 207\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent splicing factor 3b subunit 3 (spliceosome associated protein 130) (sap 130) (sf3b130) (pre-mrna splicing factor sf3b 130 kda subunit). [source:swissprot;acc:q15393]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 4771.21\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5961.43\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.24946\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 208\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent voltage-dependent calcium channel gamma-8 subunit (neuronal voltage- gated calcium channel gamma-8 subunit). [source:swissprot;acc:q8wxs5]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 4068.78\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 5082.18\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.24907\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 209\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent voltage-dependent calcium channel gamma-3 subunit (neuronal voltage- gated calcium channel gamma-3 subunit). [source:swissprot;acc:o60359]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 210\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent voltage-dependent calcium channel gamma-2 subunit (neuronal voltage- gated calcium channel gamma-2 subunit). [source:swissprot;acc:q9y698]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 4068.82\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5082.21\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.24906\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 211\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent voltage-dependent calcium channel gamma-4 subunit (neuronal voltage- gated calcium channel gamma-4 subunit). [source:swissprot;acc:q9ubn1]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 4068.91\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5082.27\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.24905\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 212\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent transcription factor iiib 90 kda subunit (tfiiib90) (htfiiib90) (b- related factor 1) (hbrf) (tata box-binding protein-associated factor, rna polymerase iii, subunit 2) (taf3b2). [source:swissprot;acc:q92994]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 4446.72\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 5553.79\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.24896\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 213\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent nucleolar protein family a, member 1; gar1 protein. [source:refseq;acc:nm\_018983]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 214\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent voltage-dependent calcium channel gamma-5 subunit (neuronal voltage- gated calcium channel gamma-5 subunit). [source:swissprot;acc:q9uf02]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 4074.83\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5086.49\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.24827\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 215\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent transforming protein p21a (k-ras 2a) (ki-ras) (c-k-ras). [source:swissprot;acc:p01116]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 16074\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 12888.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.24717\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 216\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent leucine-rich repeat protein shoc-2 (ras-binding protein sur-8). [source:swissprot;acc:q9uq13]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 16071.6\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 12886.8\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.24714\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 217\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent ral guanine nucleotide dissociation stimulator-like 2 (ralgds-like factor) (ras-associated protein rab2l). [source:swissprot;acc:o15211]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 218\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent transforming protein p21/h-ras-1 (c-h-ras). [source:swissprot;acc:p01112]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 16070.4\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 12886\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.24712\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 219\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent transforming protein n-ras. [source:swissprot;acc:p01111]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 16069.8\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 12885.6\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.24711\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 220\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent mannosyl-oligosaccharide 1,2-alpha-mannosidase ib (ec 3.2.1.113) (processing alpha-1,2-mannosidase ib) (alpha-1,2-mannosidase ib) (mannosidase alpha class 1a member 2). [source:swissprot;acc:o60476]\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 41482.5\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 33356.5\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.24361\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 221\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent cytohesin 1 (sec7 homolog b2-1). [source:swissprot;acc:q15438]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 222\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent cytohesin 2 (arf nucleotide-binding site opener) (arno protein) (arf exchange factor). [source:swissprot;acc:q99418]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 223\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent cytohesin 4. [source:swissprot;acc:q9uia0]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 224\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent cytohesin 3 (arf nucleotide-binding site opener 3) (arno3 protein) (general receptor of phosphoinositides 1) (grp1). [source:swissprot;acc:o43739]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 225\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent myosin heavy chain, cardiac muscle alpha isoform (myhc-alpha). [source:swissprot;acc:p13533]\vspace{3pt}}&\multirow{8}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 9035\vspace{3pt}}}&\multirow{8}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 7279.6\vspace{3pt}}}&\multirow{8}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.24114\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 226\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent myosin heavy chain, skeletal muscle, fetal (myosin heavy chain iib) (myhc-iib). [source:swissprot;acc:q9y623]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 227\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent myosin heavy chain, skeletal muscle, perinatal (myhc-perinatal). [source:swissprot;acc:p13535]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 228\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent myosin heavy chain, skeletal muscle, adult 2 (myosin heavy chain iia) (myhc-iia). [source:swissprot;acc:q9ukx2]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 229\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent myosin heavy chain, fast skeletal muscle, embryonic (muscle embryonic myosin heavy chain) (smhce). [source:swissprot;acc:p11055]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 230\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent myosin heavy chain, skeletal muscle, adult 1 (myosin heavy chain iix/d) (myhc-iix/d). [source:swissprot;acc:p12882]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 231\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent myosin heavy chain, cardiac muscle beta isoform (myhc-beta). [source:swissprot;acc:p12883]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 232\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent dj756n5.1.1 (continues in em:al133324 as dj1161h23.3) (fragment). [source:sptrembl;acc:q9h430]\vspace{3pt}}&&&\\\hline nd{longtable}
Legend:
- Rank is the rank after comparing the two networks
- Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray
- Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.
- Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them
- Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.
- Filtered specifies whether we only included the high confidence microarry measurements or not.

- http://analysis.yellowcouch.org/